Story excerpt provided by Dayton Business Journal.
Written by Tristan Navera.
Having raised $1.2 million in venture capital, biotech group Genetesis has decided to move to a new home in Mason as it seeks to commercialize.
The company is bringing to market a technology that lets doctors detect and localize cardiovascular issues in a non-invasive way. Backed by CincyTech, as well as billionaire Mark Cuban, the company will move to the Mason Tech Elevator as its founders scale the business, prepare for more clinical testing and commercialization.
Click here to read the complete article.
Originally published April 25, 2017.